Filing Details
- Accession Number:
- 0001179110-14-000716
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-08 17:21:20
- Reporting Period:
- 2014-01-06
- Filing Date:
- 2014-01-08
- Accepted Time:
- 2014-01-08 17:21:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204787 | Clive Meanwell | 8 Sylvan Way Parsippany NJ 07054 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-06 | 3,302 | $28.02 | 301,075 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-06 | 3,302 | $38.13 | 297,773 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-01-07 | 24,627 | $28.02 | 322,400 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-07 | 24,627 | $38.13 | 297,773 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right-to-buy) | Disposition | 2014-01-06 | 3,302 | $0.00 | 3,302 | $28.02 |
| Common Stock | Stock Option (right-to-buy) | Disposition | 2014-01-07 | 24,627 | $0.00 | 24,627 | $28.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,627 | 2014-12-14 | No | 4 | M | Direct | |
| 0 | 2014-12-14 | No | 4 | M | Direct |
Footnotes
- The common stock sales were effected pursuant to a Rule 10b5-1 program adopted by Dr. Meanwell on October 25, 2013.
- Represents the weighted average sales price of the shares sold ranging from a low of $38.09 to a high of $38.30 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $38.09 to a high of $38.26 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This option vested in forty-eight equal installments beginning on January 14, 2005.
- Not applicable.
Billionaire Hedge Funds
